Rani Therapeutics
RANI
RANI
63 hedge funds and large institutions have $60.5M invested in Rani Therapeutics in 2025 Q4 according to their latest regulatory filings, with 36 funds opening new positions, 15 increasing their positions, 0 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
37.36% more ownership
Funds ownership: 8.57% → 45.92% (+37%)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
63
Holding in Top 10
1
Calls
$12.7M
Puts
$293K
Top Buyers
| 1 | +$12.8M | |
| 2 | +$12.8M | |
| 3 | +$9.81M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$6.37M |
| 5 |
LP
Longaeva Partners
Chicago,
Illinois
|
+$3.19M |
Top Sellers
| 1 | -$683K | |
| 2 | -$56K | |
| 3 | -$23.7K | |
| 4 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$22K |
| 5 |
Brown Advisory
Baltimore,
Maryland
|
-$16.4K |
